The present invention provides kinase inhibitors of Formula (I). Wherein R
1
, R
2
, X and Z are as described herein, or a pharmaceutically acceptable salt thereof.
Pyrazole-Isoquinoline Urea Derivatives as P38 Kinase Inhibitors
申请人:De Dios Alfonso
公开号:US20080275056A1
公开(公告)日:2008-11-06
The present invention provides kinase inhibitors of Formula (I) wherein R1, R2, and X are as described herein, or a pharmaceutically acceptable salt thereof.
Pyrazole-isoquinoline urea derivatives as p38 kinase inhibitors
申请人:Eli Lilly and Company
公开号:US07582638B2
公开(公告)日:2009-09-01
The present invention provides kinase inhibitors of Formula (I) wherein R1, R2, and X are as described herein, or a pharmaceutically acceptable salt thereof.
The present invention provides kinase inhibitors of Formula (I). Wherein R1, R2, X and Z are as described herein, or a pharmaceutically acceptable salt thereof.